Relevant bibliographies by topics / Injecting drug use / Books
To see the other types of publications on this topic, follow the link: Injecting drug use.

Books on the topic 'Injecting drug use'

Author: Grafiati
Published: 4 June 2021
Last updated: 21 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Injecting drug use.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

McElrath, Karen. Drug use and risk behaviours among injecting drug users. Belfast: Drug & Alcohol Information Research Unit, Department of Health, Social Services and Public Safety, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Network, Global Youth. HIV prevention among young injecting drug users. New York, NY: United Nations Office on Drugs and Crime, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Johannes, Jager, ed. Hepatitis C and injecting drug use: Impact, costs and policy options. Luxembourg: OOPEC, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Taylor, Avril. Women drug users: An ethnography of a female injecting community. Oxford [England]: Clarendon Press, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Marsh, Alison. The Australian national AIDS and injecting drug use study, Perth, 1989. Bentley, WA: National Centre for Research into the Prevention of Drug Abuse, Curtin University of Technology, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

European Monitoring Centre for Drugs and Drug Addiction, ed. Injecting drug use, risk behaviour and qualitative research in the time of AIDS. Luxembourg: Office for Official Publications of the European Communities, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Oinam, Archana. Exploring the links between drug use and sexual vulnerability among young female injecting drug users in Manipur. New Delhi: Population Council, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Oinam, Archana. Exploring the links between drug use and sexual vulnerability among young female injecting drug users in Manipur. New Delhi: Population Council, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Joint United Nations Programme on HIV/AIDS. The Asian harm reduction network: Supporting responses to HIV and injecting drug use in Asia. Geneva, Switzerland: UNAIDS, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

David, Silver, ed. Joint and soft tissue injection: Injecting with confidence. 3rd ed. Abingdon: Radcliffe Medical Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Joint and soft tissue injection: Injecting with confidence. 2nd ed. Abingdon, Oxon: Radcliffe Medical Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Loxley, Wendy. In the same vein: First report of the Australian Study of HIV and Injecting Drug Use (ASHIDU). Perth, W.A: National Centre for Research into the Prevention of Drug Abuse, Curtin University, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Australian National AIDS and Injecting Drug Use Study. Not in a fit: Third report of the Australian National AIDS and Injecting Drug Use Study. Surry Hills, N.S.W: The Study, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Marsh, Alison. Women at risk of HIV/AIDS: Unsafe behaviour among women illicit injecting drug users in Perth. Perth, WA: Curtin University of Technology, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Loxley, Wendy. Young injecting drug users and the risk of HIV/AIDS: Psycho-social and environmental constraints on safer drug using and sexual behaviour. Perth, W. A: Curtin University of Technology, National Centre for Research into the Prevention of Drug Abuse, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Jarlais, Don Des. AIDS and intravenous drug use. [Washington, D.C.]: U.S. Dept. of Justice, National Institute of Justice, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Association, Canadian Public Health. HIV, AIDS, and injection drug use: A national action plan. Canada]: Canadian Public Health Association, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Gianino, Janet M. Intrathecal drug therapy for spasticity and pain: Practical patient management. New York: Springer, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Antipsychotic long-acting injections. New York: Oxford University Press, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Alter, Katharine E., and Nicole A. Wilson. Botulinum neurotoxin injection manual. New York, NY: Demos Medical Publishing, LLC, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Knott, P. Daniel (Philip Daniel), ed. Techniques of botulinum toxin injections in the head and neck. San Diego, CA: Plural Pub., 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Millar, John S. HIV, hepatitis, and injection drug use in British Columbia: Pay now or pay later? Victoria, B.C: Office of the Provincial Health Officer, B.C. Ministry of Health, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

McHutchion, Rick. HIV prevention and injection drug use in Alberta: Literature review : HIV prevention and non prescription needle use project. [Edmonton, Alta.]: Alberta Health, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Jürgen, Fischer. Atlas of injection therapy in pain management. Stuttgart: Thieme, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

National, Workshop on HIV Infection and Injection Drug Use (1st 1990 Montréal Québec). The First National Workshop on HIV Infection and Injection Drug Use: Strategies for prevention, Montreal, Quebec, March 26-27, 1990 : report. Ottawa, Ont: Canadian Public Health Association, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

(India), National AIDS Control Organization. Guidelines on safe disposal of used needles and syringes in the context of targeted intervention for injecting drug users. New Delhi: National AIDS Control Organisation, Dept. of AIDS Control, Ministry of Health and Family Welfare, Govt. of India, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Ian, Reilly, ed. Foot and ankle injection techniques: A practical guide. Edinburgh: Churchill Livingstone, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Council of Europe. Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group). Risk reduction linked to the use of substances other than by injection: Proceedings [of] a seminar [held] Strasbourg (France),21-22 February 2002. Strasbourg: Council of Europe, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Gupta, Anita. Interventional pain medicine. New York: Oxford University Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Silver, Trevor. Joint and soft tissue injection. Oxford: Radcliffe Medical Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Moriarty, Kate Coleman. Botulinum toxin in facial rejuvenation. Edinburgh: Mosby, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Company, Milady Publishing, ed. Professional services for men: Haircoloring and hair restoration. Australia: Thomson Delmar Learning, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Milloy, M.-J. Injecting While Incarcerated. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0003.

Full text
Abstract:
Beginning approximately coincident with the advent of the global HIV pandemic, a growing number of qualitative and quantitative epidemiological studies have investigated the phenomenon of the injection of illicit psychoactive substances by individuals held within correctional settings. Empirical studies reveal that incarceration is a common experience for people who use illicit drugs, and injection while incarcerated (IWI) is an unintended if widespread consequence of the prohibition-based approach to regulating psychoactive drugs. Analyses of the spread of HIV, hepatitis C virus (HCV), and other blood-borne pathogens among injection drug users have identified IWI as an important risk factor. Although a number of evidence-based responses have been developed to mitigate the risks associated with IWI, they are unavailable to the vast majority of imprisoned people who use injection drugs.
APA, Harvard, Vancouver, ISO, and other styles
34

Social Science of the Syringe: A Sociology of Injecting Drug Use. Taylor & Francis Group, 2017.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Small, Will, and Ryan McNeil. Understanding the Risk Environment Surrounding Drug Use in Prisons. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0011.

Full text
Abstract:
Qualitative research is uniquely positioned to advance understanding of the role of social and structural factors in shaping drug use and drug-related harms in prison settings and following release. This chapter critically reviews the qualitative literature examining drug use within the prison risk environment and following release, while identifying research gaps and directions for future inquiry. The extant literature has documented: (1) how drug use in prisons is shaped by which drugs are available, their pharmacological effects, and correctional policies; (2) how injection-related risk and syringe sharing are shaped by social and structural forces within prisons (including policies restricting syringe access) which increase the potential for drug-related harm; (3) how withdrawal and detoxification experiences in custody both foster participation in high-risk injecting practices (eg, syringe-sharing) and facilitate injection cessation and drug abstinence; (4) how inmates and staff view prison-based methadone maintenance therapy, the experiences of those receiving treatment, and barriers to scaling up methadone programs; and, (5) how transitions from prison to community shape health access, harms, and drug use patterns. By documenting prisoners’ drug-related experiences, and situating these experiences within their social, structural, and environmental contexts, these studies have generated insights beyond what is possible using other research approaches. In doing so, they have identified features of prison and post-release risk environments amenable to modification. There is an urgent need to scale up qualitative studies of prison and post-release risk environments, to better inform targeted public health interventions. Emerging interventions, including prison-based syringe exchange, should similarly be examined using qualitative approaches to more fully document their potential impacts on drug-related risks and harms.
APA, Harvard, Vancouver, ISO, and other styles
36

Bloor, M. Estimating the Prevalence of Injecting Drug Use and Serious Drug Use in Wales (Working Papers for the 1990's). Social Research Unit, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Winter, Rebecca J., and Margaret E. Hellard. Drug Use in Prisoners and Hepatitis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0009.

Full text
Abstract:
A corollary of the high proportion of people who inject drugs cycling through prisons worldwide is the accompanying high prevalence of viral hepatitis, particularly hepatitis C (HCV). Prisons have the potential to either escalate or interrupt the transmission of viral hepatitis: prisons that do not provide access to even basic prevention programs are high-risk environments for viral hepatitis transmission. In contrast, prisons can also reduce prevalence through testing and treatment programs. This chapter provides an overview of the global prevalence and incidence of HCV and hepatitis B (HBV) in prisons and the occurrence of known transmission vectors, including injecting drug use, tattooing and other body modification practices, and unprotected sexual intercourse. It discusses policy and practice options to reduce the risk behaviors associated with HCV and HBV transmission, prevent transmission through vaccination, and potentially expand viral hepatitis treatment in prisons using new directly acting anti-viral medication, and the prospect of treatment as prevention.
APA, Harvard, Vancouver, ISO, and other styles
38

Exploring the links between drug use and sexual vulnerablity among young female injecting drug users in Manipur. New Delhi: Population Council, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Exploring the links between drug use and sexual vulnerablity among young female injecting drug users in Manipur. New Delhi: Population Council, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Carpentier, Chloé, Luis Royuela, Linda Montanari, and Philip Davis. The Global Epidemiology of Drug Use in Prison. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0002.

Full text
Abstract:
This chapter provides an overview of drug use in prison. It is centered on illicit drug use in Europe, where the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has been collecting aggregated data from various sources for 15 years. It also reviews, based on published literature, data from the four other global regions. A total of 59 studies from 31 countries in the five world regions were included for analysis. Results show that the prevalence of drug use varies greatly between studies. Lifetime prevalence of any illicit drug use in prison ranges between 2% to 76% worldwide with, in most cases, cannabis being the most frequently reported substance. More recent (past-month) illicit drug use is reported by <1% to 65% of inmates, while <1% to 39% report injecting illicit drugs during their stay in prison. Alcohol use in prison is reported in a few studies only, varying between 2% to 77% while the prevalence of current tobacco smoking ranges between 4% to 90%. In general, available data are scarce and patchy, especially outside Europe, with large variations in methodology relating to sampling strategy and measurement. This heterogeneity hampers comparison and may, in part, account for the wide range of prevalence estimates. Comparable methods and measures of drug use and its consequences in prison populations are needed to facilitate international comparisons and provide the sound information needed for development and implementation of drug interventions in various prison settings across the globe.
APA, Harvard, Vancouver, ISO, and other styles
41

1965-, Southgate Erica, and Australian National Council on Drugs., eds. Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Canberra: Australian National Council on Drugs, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

(Contributor), David Silver, ed. Joint and Soft Tissue Injection: Injecting With Confidence. 4th ed. Radcliffe Publishing, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Silver, Trevor. Joint and Soft Tissue Injection: Injecting with Confidence. Taylor & Francis Group, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Silver, Trevor, and David Silver. Joint and Soft Tissue Injection: Injecting with Confidence, 5th Edition. Taylor & Francis Group, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Larney, Sarah, Mark Stoové, and Stuart A. Kinner. Substance Use After Release from Prison. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0006.

Full text
Abstract:
This chapter discusses the substantial proportion of prisoners globally who have a history of alcohol, tobacco, and other drug use and dependence. Incarceration usually provides a period of abstinence or reduced substance use, but this reduction is often transientand many ex-prisoners rapidly return to pre-incarceration levels of substance use. Substance use after release from prison is affected by both individual factors, such as substance use history and personal expectations, and interpersonal factors, such as social networks. Released prisoners often return to environments in which drugs are readily available and substance use is accepted or normative. Structural factors, such as poor access to substance use treatment and other health services, unstable housing and limited employment options, can create additional stressors that increase the risk of harmful substance use. Given the paucity of epidemiological evidence, the natural history of substance use after release from prison remains poorly understood. In particular, there is a dearth of evidence relating to resumption of alcohol, tobacco, and non-injecting illicit drug use following release from prison. Furthermore, although substance use in ex-prisoners is affected by structural and interpersonal factors, interventions to address problematic substance use typically focus on the individual. Additional research in this area is urgently needed to inform evidence-based policies and interventions.
APA, Harvard, Vancouver, ISO, and other styles
46

Bialer, Philip, Kenneth Ashley, and John Grimaldi. Substance-Related and Addictive Disorder? The Special Role in HIV Transmission. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0014.

Full text
Abstract:
Substance use disorders have been linked to HIV/AIDS since the beginning of the epidemic. Injecting drug use can serve as a mode of viral transmission and in some parts of the world and among certain populations is the primary vector of transmission. Substances of misuse implicated in HIV transmission include alcohol, cocaine, heroin, methamphetamine, and Ecstasy. Use of both non-injecting drugs and alcohol is also associated with increased sexual and other risk-taking behaviors and seroconversion. In addition, substance use disorders and other psychiatric disorders often coexist and can have profound effects on the medical management of HIV/AIDS as well as on a person’s social interaction and quality of life. Many people with HIV/AIDS therefore suffer from triple diagnoses necessitating comprehensive evaluation and treatment and a team approach involving medical, mental health, and substance use caregjvers. Treatment can include detoxification, harm reduction, individual, group, and family therapy, medication, and awareness of potential drug interactions.
APA, Harvard, Vancouver, ISO, and other styles
47

Snow, Kathryn, and Michael Levy. Harm Reduction in Prisons. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199374847.003.0017.

Full text
Abstract:
Interventions intended to minimize the harms of injecting drug use, particularly drug overdose and exposure to blood-borne viruses, have a long history of implementation in some community settings but are frequently unavailable in prisons. The denial of harm reduction measures to prisoners who inject drugs violates their right to non-discriminatory healthcare, as well as other facets of international human rights law. Evidence is available from several programs in diverse settings which demonstrates that it is possible to implement many harm reduction interventions in prisons, that such programs can reduce the risk of drug-related harms, and that concerns regarding unintended negative consequences of such programs are often unfounded. This chapter provides an overview of the key harm reduction measures relevant to the prison setting, with a particular focus on the provision of sterile injecting equipment to prisoners via needle and syringe exchange programs, and on the provision of the opioid antagonist naloxone as first-line treatment for opioid overdose to people while in prison and on leaving prison. The chapter reviews the legal basis for providing these and other harm reduction measures to prisoners, outlines the evidence that supports specific interventions, and highlights topics on which further research is needed.
APA, Harvard, Vancouver, ISO, and other styles
48

Degenhardt, Louisa, Wayne Hall, and Chiara Bucello. Illicit Drugs. Edited by Kenneth J. Sher. Oxford University Press, 2014. http://dx.doi.org/10.1093/oxfordhb/9780199381678.013.016.

Full text
Abstract:
Although illicit drug use has been documented across the world, the quality of these estimates is best in the developed countries of Europe, North America, and Australasia. Regular use, “problem drug use,” and drug dependence are less frequently measured but are important to quantify in order to identify disease burden. This paper reviews European, North American, and Australasian estimates of illicit drug use, problem drug use, and drug dependence and presents risk factors of illicit drug use. These risk factors include health risks related to cannabis and mortality associated with problem drug use and injecting drug use. Drug-related morbidity is reviewed, including nonfatal overdose, HIV/AIDS, and hepatitis B and C. Future research needs to focus on obtaining better estimates of mortality and morbidity to better understand the harms associated with illicit drug dependence.
APA, Harvard, Vancouver, ISO, and other styles
49

Euster, Caren. Infection in the Intravenous Drug User. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0058.

Full text
Abstract:
Injection drug abuse has spread worldwide and is increasing among young adults and adolescents. This chapter focuses on the management of acute infectious consequences of injection drug use (IDU), including skin and soft tissue infections, endocarditis, and systemic infections. The approach to infection is determined based upon etiology: local (injection site) infections, infections distant to the injection site, systemic infections, complications of primary infections, modifying factors, and infections associated with the patient with IDU’s lifestyle. Infections in patients with a history of injection drug use can affect multiple systems. The most commonly affected systems include the skin (eg, abscess), heart (eg, endocarditis), lung (eg, pneumonia), kidney, and brain (eg, septic emboli secondary to endocarditis).
APA, Harvard, Vancouver, ISO, and other styles
50

Mohamed, Mahmood Nazar, Hassan Ali, Faisal Ibrahim, and Ahamad Jusoh. Estimation of drug users and injecting drug users in Malaysia. UUM Press, 2005. http://dx.doi.org/10.32890/9833282415.

Full text
Abstract:
Malaysia treats the problem of drug addiction as a security issue. Since it was identified in the early 70s, the number of drug addicts is constantly on the rise. At present, the government provides all statistics pertaining to the number of drug users, abusers and addicts in the country.The monograph contains the full report that was submitted to the Ministry of Health and WHO-WPR. It reports the national data for drug addiction for the year 2002, and a detailed description of the methodology used to arrive at the estimates.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Injecting drug use' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography